Can a 26‑kg child receive a single intramuscular dose of 1300 mg ceftriaxone (50 mg/kg) for treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Give 1300 mg of Ceftriaxone as a Single Dose to a 26-kg Child?

Yes, you can administer 1300 mg (50 mg/kg) of ceftriaxone as a single intramuscular or intravenous dose to a 26-kg child for specific indications, particularly gonococcal bacteremia, arthritis, or disseminated infection, where this dosing is explicitly recommended by CDC guidelines. 1, 2

Weight-Based Dosing Calculation

  • For a 26-kg child, the calculation is straightforward: 50 mg/kg × 26 kg = 1300 mg, which falls well below the maximum single dose of 2 grams for non-meningeal infections. 2, 3

  • This dose is appropriate for children weighing <45 kg with gonococcal bacteremia or arthritis, where CDC guidelines specifically recommend 50 mg/kg IM or IV once daily for 7 days (maximum 1 g per day). 1, 2

Indication-Specific Guidance

Gonococcal Infections (Bacteremia/Arthritis)

  • The CDC explicitly recommends 50 mg/kg IM or IV once daily for children <45 kg with gonococcal bacteremia, arthritis, or disseminated infection, making 1300 mg appropriate for this 26-kg patient. 1, 2

  • Treatment duration is 7 days, extended to 10-14 days if meningitis is documented. 1, 2

Other Serious Non-Meningeal Infections

  • For serious miscellaneous infections (pneumonia, sepsis, osteomyelitis, pyelonephritis), the FDA-approved dosing is 50-75 mg/kg/day, which can be given once daily or divided every 12 hours, with a maximum of 2 grams daily. 3, 2

  • A single 1300-mg dose (50 mg/kg) is within the recommended range and has been extensively studied in pediatric populations. 4, 5, 6

Meningitis (Different Dosing)

  • For bacterial meningitis, the dose is 100 mg/kg/day (which would be 2600 mg for this child), not 50 mg/kg, so 1300 mg would be inadequate for CNS infections. 1, 2, 3

Evidence Supporting Once-Daily Dosing at 50 mg/kg

  • Multiple pediatric studies demonstrate that 50 mg/kg once daily achieves adequate trough concentrations exceeding the MIC of common pathogens (H. influenzae, S. aureus, E. coli, S. pneumoniae) for non-CNS infections. 4, 5

  • A study of 35 children treated with 50 mg/kg once daily showed that all but one patient had trough levels exceeding the MIC of the infecting organism, with a satisfactory clinical response in all evaluable patients. 5

  • Another study of 201 children receiving 50-80 mg/kg once daily reported an overall clinical cure rate of 94% and bacteriologic cure rate of 97% for serious infections including pneumonia, cellulitis, osteomyelitis, and pyelonephritis. 6

  • Recent pharmacokinetic modeling in critically ill children confirms that 100 mg/kg once daily provides adequate exposure for susceptible pathogens (MIC ≤0.5 mg/L) in most patients, with 50 mg/kg twice daily recommended only for highly resistant organisms or augmented renal clearance. 7

Route of Administration

  • Both intramuscular and intravenous routes are acceptable for this dose. 1, 2, 3

  • Intramuscular injection should be administered deep into a large muscle mass, and families should be counseled that IM injection can be painful. 2

  • For IV administration, the dose should be infused over 30-60 minutes in pediatric patients to reduce adverse effects. 3, 7

Maximum Dose Considerations

  • The 1300-mg dose is well below the pediatric maximum of 2 grams daily for non-meningeal infections and 4 grams daily for meningitis. 2, 3

  • CDC and AAP guidelines emphasize that pediatric doses should not exceed adult doses even when weight-based calculations suggest higher amounts. 2

Critical Contraindications

  • Do not use ceftriaxone in hyperbilirubinemic neonates, especially premature infants, due to risk of bilirubin encephalopathy. 2, 3

  • Do not mix with calcium-containing solutions in neonates ≤28 days due to risk of fatal ceftriaxone-calcium precipitation. 3

  • For neonates requiring IV administration, infuse over 60 minutes to reduce bilirubin displacement risk. 3

Practical Algorithm for 26-kg Child

  1. Confirm indication: Is this for gonococcal bacteremia/arthritis (50 mg/kg once daily for 7 days) or another serious infection (50-75 mg/kg/day once daily or divided)?

  2. Calculate dose: 50 mg/kg × 26 kg = 1300 mg (appropriate single dose)

  3. Verify not meningitis: If CNS infection suspected, use 100 mg/kg/day (2600 mg), not 1300 mg

  4. Choose route: IM (deep into large muscle, counsel about pain) or IV (infuse over 30-60 minutes)

  5. Plan duration: 7 days for gonococcal infections; 7-14 days for other serious infections depending on clinical response

  6. Add chlamydia coverage: If gonococcal infection, add azithromycin 1 g orally (or 20 mg/kg for children <45 kg) as single dose if Chlamydia trachomatis not excluded. 1, 3

Common Pitfalls to Avoid

  • Do not underdose meningitis: 1300 mg is inadequate for CNS infections; use 100 mg/kg/day (2600 mg for this child). 1, 3

  • Do not forget chlamydia coverage: Gonococcal infections require concurrent antichlamydial therapy if chlamydia not ruled out. 1, 3

  • Do not use in neonates with hyperbilirubinemia: Ceftriaxone displaces bilirubin from albumin, risking kernicterus. 2, 3

  • Do not mix with calcium in neonates: Fatal precipitates can form; this is less of a concern in older children but still avoid Y-site calcium administration. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.